Papers
2
Total Citations
9
H-Index
1
About
Dr. Luke Patten is a urologic surgeon and clinical researcher whose work centers on optimizing perioperative care for patients undergoing radical cystectomy for bladder cancer. His primary research focus is the implementation and refinement of Enhanced Recovery After Surgery (ERAS) protocols, with a particular emphasis on the role of alvimopan—a peripherally acting mu-opioid receptor antagonist—in reducing postoperative ileus. In his most cited study (2021, 8 citations), Dr. Patten demonstrated that incorporating alvimopan into an ERAS protocol significantly decreased hospital length of stay following radical cystectomy. This retrospective analysis of 296 patients provided compelling evidence that multimodal recovery pathways can improve surgical outcomes and reduce healthcare burdens. His subsequent work (2020, 1 citation) further reinforced alvimopan’s role as an essential component of these protocols. By systematically evaluating how targeted pharmacologic interventions enhance recovery, Dr. Patten has contributed actionable insights for urologic oncology teams seeking to standardize and improve postoperative care. His research bridges clinical practice and evidence-based protocol design, offering a model for reducing morbidity and accelerating recovery in major cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2